226 related articles for article (PubMed ID: 32945790)
21. [HPV: Carcinogenic implications and preventive measures].
Bernichon E; Espenel S; Méry B; Trone JC; Rehalia-Blanchard A; He YM; Rancoule C; Magné N
Presse Med; 2019; 48(7-8 Pt 1):756-766. PubMed ID: 31307878
[TBL] [Abstract][Full Text] [Related]
22. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
Borracci RA; Segal SV; Méndez JH
Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
[TBL] [Abstract][Full Text] [Related]
24. Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full….
Frazer IH
Viral Immunol; 2018 Mar; 31(2):80-85. PubMed ID: 29298130
[TBL] [Abstract][Full Text] [Related]
25. EBCOG position statement: Gender neutral HPV vaccination for young adults.
Verheijen RHM; Mahmood T; Donders G; Redman CWE; Wood P
Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():187-189. PubMed ID: 31992466
[TBL] [Abstract][Full Text] [Related]
26. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
de Martel C; Plummer M; Vignat J; Franceschi S
Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic human papillomavirus vaccines: past, present and future.
Anderson LA
Pathology; 2012 Jan; 44(1):1-6. PubMed ID: 22157686
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and burden of HPV-related disease.
Serrano B; Brotons M; Bosch FX; Bruni L
Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():14-26. PubMed ID: 29037457
[TBL] [Abstract][Full Text] [Related]
29. [Human papillomavirus (HPV) vaccination in males : evidence and practice].
Perrin A; Iselin C
Rev Med Suisse; 2019 Nov; 15(673):2202-2204. PubMed ID: 31778050
[TBL] [Abstract][Full Text] [Related]
30. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
31. HPV-Related Cancers: A Growing Threat to U.S. Military Health and Readiness.
Seay J; Matsuno R; Buechel J; Tannenbaum K; Wells N
Mil Med; 2022 May; 187(5-6):149-154. PubMed ID: 34697641
[TBL] [Abstract][Full Text] [Related]
32. Early Detection of Human Papillomavirus-Driven Oropharyngeal Cancer Using Serology From the Study of Prevention of Anal Cancer.
Waterboer T; Brenner N; Gallagher R; Hillman RJ; Jin F; Grulich A; Poynten IM
JAMA Oncol; 2020 Nov; 6(11):1806-1808. PubMed ID: 33001163
[TBL] [Abstract][Full Text] [Related]
33. Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.
Gordon J; Bail J
NASN Sch Nurse; 2023 May; 38(3):114-120. PubMed ID: 36691362
[TBL] [Abstract][Full Text] [Related]
34. In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers.
Lehtinen M; Gray P; Louvanto K; Vänskä S
Expert Rev Vaccines; 2022 Jun; 21(6):735-738. PubMed ID: 35404177
[No Abstract] [Full Text] [Related]
35. Young Deaf Adults' Knowledge of Human Papillomavirus and Human Papillomavirus Vaccine's Effectiveness in Preventing Cervical, Anal, Penile, and Oral Cancer.
Spellun AH; Moreland CJ; Kushalnagar P
J Pediatr Adolesc Gynecol; 2019 Jun; 32(3):293-299. PubMed ID: 30529699
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.
Steinau M; Saraiya M; Goodman MT; Peters ES; Watson M; Cleveland JL; Lynch CF; Wilkinson EJ; Hernandez BY; Copeland G; Saber MS; Hopenhayn C; Huang Y; Cozen W; Lyu C; Unger ER;
Emerg Infect Dis; 2014 May; 20(5):822-8. PubMed ID: 24751181
[TBL] [Abstract][Full Text] [Related]
37. HPV Vaccine Slashes Rates of Oral Infection.
Cancer Discov; 2017 Jul; 7(7):OF6. PubMed ID: 28526738
[TBL] [Abstract][Full Text] [Related]
38. Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers.
Aninye IO; Berry-Lawhorn JM; Blumenthal P; Felder T; Jay N; Merrill J; Messman JB; Nielsen S; Perkins R; Rowen T; Saslow D; Trimble CL; Smith-McCune K
J Womens Health (Larchmt); 2021 Dec; 30(12):1667-1672. PubMed ID: 34871035
[TBL] [Abstract][Full Text] [Related]
39. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
40. For cancers caused by HPV, two vaccines were just the beginning.
Peres J
J Natl Cancer Inst; 2011 Mar; 103(5):360-2. PubMed ID: 21357595
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
